Public COA audit
MOTS-c
Audited September 5, 2026
Several fields check out, but we found issues worth reviewing before you rely on this document.
- Legitimacy
- 92
- Confidence
- 93%
- Panels
- 2/7
- Purity (printed)
- 99.9%
Scored high because the document is mostly consistent but carries soft concerns, limited panel coverage (2/7), and 1 soft concern. To improve: include identity, purity, and endotoxin at minimum.
Document details
Fields extracted from the certificate — not order or payment data.
- Batch / lot
- SNEVP5F
- Identity method
- FTIR (USP <197A>)
- Sample date
- 2026-03-25
- Issue date
- 2026-03-30
Original certificate
Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.
7-panel checklist
Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.
2 of 7 present · 2 passed · 0 failed · 0 reported · 5 missing
Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.
Identity
Tested · passed · core
Compound identity confirmed (e.g. HPLC, mass spec).
FTIR sample spectrum confirms the presence of MOTS-c with addition of excipient(s)/fillers
Purity
Tested · passed · core
Reported purity percentage for the analyte.
99.9%
Heavy metals
Not on this certificate file
Lead, arsenic, cadmium, mercury, or similar limits.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Microbial
Not on this certificate file
Bioburden / microbial limits testing.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Endotoxin
Not on this certificate file · core
LAL or chromogenic endotoxin assay.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Sterility
Not on this certificate file
Sterility testing where applicable.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Residual solvent / water
Not on this certificate file
Residual solvents or water content limits.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
How to read this
Had data · good
Panel present with a pass (or clear acceptance).
Had data · bad
Panel present with a fail — a concrete quality signal.
Had data · unclear
Value reported without an explicit pass/fail mark.
Missing on this file
Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.
Findings
Evidence-linked observations from this audit.
High HPLC purity
99.9% purity by HPLC (USP <621>) exceeds ≥98% specification. This is normal for research-grade peptides and supported by clean chromatogram showing single dominant peak at 5.816 min.
Identity confirmed
FTIR spectrum confirms MOTS-c presence with excipients/fillers. FTIR graph on page 2 shows characteristic peptide bands.
Lot number present
Lot SNEVP5F clearly documented with BT Sample ID 005000039343013.
Dates valid
Sample tested 2026-03-25, report issued 2026-03-30. Both dates are on or before 2026-09-05 (current date) and logically sequenced.
Testing lab identified
BTLabs (BT Lab Testing), 5730 Corporate Way Suite 220, West Palm Beach, FL 33407. Contact info and website provided. Digital signatures from Andrea Castro, AS and Verna Zheng, AS (Scientist-II) present.
Limited scope - purity/identity only
Testing purpose explicitly states this COA does NOT provide information on particulate matter, microbial contamination, or endotoxins. This is a purity/identity-focused report. Absence of endotoxin/microbial/heavy metals panels is disclosed and does not indicate the vendor never tests for these.
Professional presentation
Document includes report number IF-824-QSA-TR006-BTL2658-42, revision control (Rev 1.0 January 2025), dual branding (BTLabs and Finnrick), verification URL, FTIR and HPLC chromatograms, and detailed test methods with USP references.
Potency within specification
Potency assay shows 11.6 mg (116.2%) against 10 mg label claim, within 90-110% specification range stated. Peptide-to-excipient ratio 1:8 is within recommended 1:2 to 1:10 range.
PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.